S.I.I.T. has strengthened its development pipeline with a new high-shear granulation line, expanding capacity for solid dosage food supplements and OTC products across European markets.
Why this matters
Demand for clean-label, high-efficacy formulations continues to accelerate. The new line lets our R&D and manufacturing teams move from concept to validated batch faster, without compromising the quality standards our partners rely on.
What changes for partners
- Shorter lead times on pilot and scale-up batches
- Wider range of dosage forms — tablets, sachets, stick-packs
- Tighter process control and full batch traceability
Speed and science are not a trade-off. Our job is to give partners both, at industrial scale.
Looking ahead
Over the coming months we will extend the same approach to our liquid dosage capabilities. To discuss a project, get in touch with our team.